Correlation Between Curative Biotechnology and Chimeric Therapeutics

Can any of the company-specific risk be diversified away by investing in both Curative Biotechnology and Chimeric Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Curative Biotechnology and Chimeric Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Curative Biotechnology and Chimeric Therapeutics Limited, you can compare the effects of market volatilities on Curative Biotechnology and Chimeric Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Curative Biotechnology with a short position of Chimeric Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Curative Biotechnology and Chimeric Therapeutics.

Diversification Opportunities for Curative Biotechnology and Chimeric Therapeutics

0.0

Correlation Coefficient

Curative Biotechnology  Chimeric Therapeutics

Pay attention - limited upside

The 3 months correlation between Curative and Chimeric is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Curative Biotechnology and Chimeric Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chimeric Therapeutics and Curative Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Curative Biotechnology are associated (or correlated) with Chimeric Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chimeric Therapeutics has no effect on the direction of Curative Biotechnology i.e., Curative Biotechnology and Chimeric Therapeutics go up and down completely randomly.

Pair Corralation between Curative Biotechnology and Chimeric Therapeutics

If you would invest  0.91  in Curative Biotechnology on August 6, 2025 and sell it today you would lose (0.26) from holding Curative Biotechnology or give up 28.57% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Curative Biotechnology  vs.  Chimeric Therapeutics Limited

Curative Biotechnology

Risk-Adjusted Performance

Weakest

Compared to the overall equity markets, risk-adjusted returns on investments in Curative Biotechnology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental drivers, Curative Biotechnology unveiled solid returns over the last few months and may actually be approaching a breakup point.

Chimeric Therapeutics

Risk-Adjusted Performance

Weakest

Over the last 90 days Chimeric Therapeutics Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable primary indicators, Chimeric Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Curative Biotechnology and Chimeric Therapeutics

The main advantage of trading using opposite Curative Biotechnology and Chimeric Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Curative Biotechnology position performs unexpectedly, Chimeric Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chimeric Therapeutics will offset losses from the drop in Chimeric Therapeutics' long position.

The idea behind Curative Biotechnology and Chimeric Therapeutics Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.